Using PSMA-PET imaging to improve prostate cancer surgery outcomes
PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life?
This study is looking at a new imaging method called PSMA-PET to help doctors plan better surgeries for men with prostate cancer by showing how far the cancer has spread, which could lead to better results and a happier recovery for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11038037 on NIH RePORTER |
What this research studies
This research investigates the use of a specialized imaging technique called PSMA-PET to enhance surgical planning for prostate cancer patients. By accurately identifying the extent of cancer spread beyond the prostate, the study aims to help surgeons determine whether nerve-sparing or more aggressive surgical approaches are necessary. This could lead to better surgical outcomes and improved quality of life for patients after surgery. The research involves comparing the effectiveness of PSMA-PET with standard imaging methods to guide treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with prostate cancer who are scheduled for prostatectomy.
Not a fit: Patients with advanced prostate cancer that has spread extensively or those not undergoing surgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise surgeries that minimize nerve damage and enhance the quality of life for prostate cancer patients.
How similar studies have performed: Previous research has shown promising results using similar imaging techniques in cancer treatment planning, indicating potential for success in this approach.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Bahler, Clinton David — Indiana University Indianapolis
- Study coordinator: Bahler, Clinton David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.